Out of total 13245 cases of color Doppler echocardiography in this period, 181 cases were diagnosed as persistent pulmonary hypertension of newborn or persistent fetal circulation. After diagnosis, all the outpatient cases were admitted to the neonatal intensive care unit (NICU) for specific management. Some of the cases were already in NICU for their existing illness.
Echocardiography parameters which were noted in each case were:
• Measurement of pulmonary artery systolic and Diastolic pressure
• Right ventricular dimension and thickness.
• Presence of atrial Septal defect or patent Ductus Arteriosus and direction of shunt through them.
• Presence of any other significant shunt.
Those who had right to left shunt were considered as persistent fetal circulation. Patients who had pulmonary hypertension associated with significant congenital lesions like large ventricular Septal defects, Aorto pulmonary window, Atrioventricular septal defects or other complex lesions were not included in the study. Birth history, antenatal history of mother like history of hypertension or diabetes, History of TORCH Infection, Gestational age of the baby, birth weight, APGAR Most of the cases are (69.06%) diagnosed at first week of life, least (5.52%) diagnosed at 4rth week. Hundred percent patient attended first follow up of echocardiography as they were hospitalized but 2 nd follow up after one month was attended by 54.34% male and 45.65% female babies.
Discussion:
Persistent fetal circulation (PFC) also known as persistent pulmonary hypertension of the newborn is defined as persistence of right to left atrial or ductal shunting or both in the presence of elevated right ventricular pressure. [1] [2] [3] Mean pulmonary artery pressure at rest is > 25 mm of Hg in such situation with normal pulmonary capillary wedge pressure. PPHN results from abnormal vascular remodeling. Increased pulmonary arterial resistance and exaggerated vascular activity. It is relatively a rare condition which is seen in newborn with respiratory distress syndrome, septicemia, meconium aspiration syndrome, diaphragmatic hernia or perinatal asphyxia or ischemia. 8, 9 In utero the fetus derives its oxygen and nutrients from placenta through the umbilical vein. Most of this blood bypasses the liver and enter into right atrium (RA). From RA blood enter into left atrium through foramen ovale and subsequently pumped into Aorta. Negligible amount of blood that enter into right ventricle from RA is subsequently pumped into Aorta through ductus arteriosus bypassing lung as pulmonary vascular resistance is very high in fetus. So fetal lung receive only 8% of ventricular output. Because a lower PVR generally promotes functional closure of the ductus and foramen ovale while a high PVR encourages PFC, it is useful to know which substances increase and which substances decrease PVR. [10] [11] [12] Factors known to lower PVR include oxygen, nitric oxide, prostacyclin, prostaglandins E 2 and D 2 , adenosine, magnesium, bradykinins, atrial natriuretic factor, alkalosis, histamine, acetylcholine, beta-adrenergic stimulation and potassium channel activation. Factors that increase PVR are hypoxia, acidosis, endothelin-1, leukotrienes, thromboxanes, platelet activating factors, prostaglandin F 2 -alpha, alpha-adrenergic stimulation and calcium channel activation [13] [14] [15] [16] . Thus, it is important to recognize clinical conditions that affect PVR and to treat them appropriately. Mechanisms that contribute to high pulmonary vascular resistances in the fetus are: Low oxygen tension b) relatively low basal production of vasodilator products (PGI, nitric oxide) c) increased production of vasoconstrictors (endothelin and leukotrienes) and altered smooth muscle activity. During last trimester, the fetal pulmonary circulation becomes progressively responsive to vasoactive Stimuli. [8] [9] [10] Immediately after birth, pulmonary artery pressure falls and blood flow increases in response to birth related stimuli. Those includes establishment of air liquid interface, rhythmic lung distension, increased oxygen tension and altered production of vasoactive substances like nitric oxide and prostaglandin. 4, 5 Mechanisms that lead to failure of fall in pulmonary resistance at birth include a) exposure to chronic or acute hypoxia at birth, b) chronic hypoxia in utero. c) Entrance of meconium into the airways d) septicemia e) cardiac malformations and others. 10, 11 The syndrome occurs in 1-2 per 1000 live births typically in full term babies. It occurs more commonly in male.
Most of the cases of PFC landed to complete recovery or death. 16 Occasionally, there may be long term sequelae such as chronic lung disease, cerebral infarction resulting in specific motor and/ or cognitive deficits, and sensorineural hearing loss. 17 An association with sudden infant death syndrome has also been suggested.PFC can be primary or secondary to other factors. Any problems or situations can result in idiopathic PFC, including hypoxia, acidosis, hypothermia, hypoglycemia etc. Secondary PFC is most commonly seen in infants with lung diseases, the most common cause being meconium aspiration. The resulting hypoxia and acidosis cause pulmonary vasoconstriction and increased rightsided pressures. Other common causes are diaphragmatic hernia, hyaline membrane disease, sepsis syndrome and pulmonary thromboembolism. These babies usually present with cyanosis, respiratory distress, oxygen dependency, low cardiac output stapes, differential cyanosis etc. Differential cyanosis is due to the difference in oxygen content in preductal and postductal blood, and is relatively specific for PFC. A positive partial pressure of arterial oxygen (PaO 2 ) gradient greater than 15 mmHg between the right radial artery and the descending aorta blood suggests PFC, but it may be absent in some cases. 17 The hyperoxia test is also positive, so PFC is suspected particularly when these conditions cannot be corrected by improved ventilation.
Chest X-ray may be normal or there may be oligaemic lung fields, congenital diaphragmatic hernia etc.
Echocardiography is the most sensitive and specific investigation which help to confirm the diagnosis of PPHN. 18, 19 Parameters used in our settings are: Infants with PFC are very sensitive to their environment and tend to be extremely unstable. They are, in general, mechanically ventilated, sedated and often paralyzed with muscle relaxants. 20, 21 Therefore, procedures such as suctioning, changing endotracheal tubes, bathing and repositioning should be kept to a minimum. Early treatment with surfactant prevents the development of PFC in cases with lung issues. Controlled hyperventilation has been used to decrease PVR by making the blood more alkaline.
The administration of cardiotonic drugs should be reserved for infants in whom myocardial dysfunction and/or persistent hypotension is documented. Exogenous, inhaled nitric oxide at low doses causes potent, sustained and selective pulmonary vasodilation. 22, 23 The patient who had decreased left ventricular size and aortic velocity had increased likelihood to need ECMO support, INO, high frequency ventilation etc. In our study only 08 cases has smaller left ventricular end diastolic areas (Table  V) and these cases required high frequency ventilation.
Ventricular volume overload and high calculated pulmonary artery systolic pressure, few with right to left shunting through ASD or PDA and they were treated successfully with high flow nasal and head box oxygen therapy along with administration of pulmonary vasodilator drugs (Table VI) . In our study most of the cases were cured (95.58%)with treatment described in (Table  VII) .Only 6.65% Patient developed idiopathic pulmonary arterial hypertension and 2.15% patient expired (Table VII) .In a study conducted in children's hospital of Philadelphia, out of 63 neonates 95% survived, 14%required ECMO, 52% required HFV, 67% INO and35% required mechanical ventilationl2. This study showed most of the patient required expensive and invasive treatment modalities for ultimate cure but in our study we achieved high rate of cure without using any expensive and invasive treatment. Most of our cases have PPHN and severe forms of PFC were only seen in isolated occasion now.
Outcome of treatment at the end of therapy was assessed by doing echocardiography at 72 hours and documented (Table VIII) .Treatment protocol formulated and used for PPHN in our neonatal intensive care unit is cheap, affordable and effective which was proved from our low mortality rate.
Conclusion:
Respiratory failure is a leading cause of death in newborn, most common cause of which is PPHN. This condition is reversible but can cause very severe and unrelenting respiratory failure and death if remain untreated Recent advancement in diagnostic procedure and treatment expanded the scope for survival in these.
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